Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study on the effect of dapagliflozin on myocardial insulin sensitivity and perfusion (DapaHeart)

Trial Profile

Study on the effect of dapagliflozin on myocardial insulin sensitivity and perfusion (DapaHeart)

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DapaHeart
  • Most Recent Events

    • 06 Oct 2023 Results investigating changes in HDL modulation of nitric oxide production with dapagliflozin and whether there is an association with myocardial flow reserve, presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
    • 19 Dec 2022 Status changed from recruiting to discontinued.
    • 29 Aug 2022 Primary endpoint (Effect of dapagliflozin on myocardial insulin sensitivity) has not been met, according to Results presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top